Give 15% off, earn 10% back on every order they place.
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Retatrutide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 27.47 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 106.46 on their own).
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €78.99 | €78.99 | -- |
| 3+ | €75.04 | €225.12 | 5% off |
| 5+Most Popular | €71.09 | €355.46 | 10% off |
| 10+ | €67.14 | €671.42 | 15% off |
Free shipping on orders over €200
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
Recommended: BAC water · stable for 21 days at 2-8°C once mixed.
99.3% average HPLC purity, verified by independent third-party testing
View report #123932 on janoshik.com →
24h dispatch, EU-wide shipping from €4.99
Supplier batch specification on every product; independent Janoshik report on selected lots
The Retatrutide Research Starter Kit provides research-grade retatrutide with reconstitution supplies for laboratory use. Retatrutide (LY3437943) is the most structurally ambitious of the current incretin-class research peptides, combining agonism at GIP, GLP-1, and glucagon receptors in a single 39-amino-acid molecule. The triple-receptor profile has prompted significant academic interest in the underlying receptor pharmacology in cell-based and animal-model assays.
The triple-agonist profile raises questions that dual agonists cannot address. GIP receptor engagement, which is absent in semaglutide and present in tirzepatide, appears to amplify in vitro signalling beyond what GLP-1 receptor activation alone produces. The addition of glucagon receptor agonism on top of that theoretically adds thermogenic and hepatic glucose-output modulation that the other incretins do not cover. Whether these effects sum, synergise, or partially antagonise each other in specific tissues is an active in vitro research question.
Researchers studying incretin receptor pharmacology, adipose biology, hepatic glucose metabolism, or CNS satiety circuitry will find retatrutide a useful complement to semaglutide and tirzepatide receptor-comparison experiments -- particularly where the goal is attributing specific effects to each receptor subtype through comparative dosing or receptor knockout in vitro models.
| Component | Quantity | Details |
|---|---|---|
| Retatrutide | 1 x 10mg | ≥98% supplier batch spec (99.3% avg across independently tested lots), lyophilized |
| Bacteriostatic Water | 1 x 5ml | Sterile, 0.9% benzyl alcohol |
| 3ml Syringes | 2 | For reconstitution and draw-up |
| 1ml Insulin Syringes | 5 | For precision dosing of research subjects in laboratory protocols |
Store lyophilized retatrutide at -20°C before reconstitution. Reconstitute with bacteriostatic water and store at 4°C, stable for up to 30 days. The fatty acid conjugation (like other long-acting GLP-1 receptor agonists) may cause some precipitation at low temperatures -- bring to room temperature and mix gently before use. Bacteriostatic water is suitable for peptides stored over more than a few days.
Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide adds glucagon receptor agonism as a third component. Glucagon receptor activation increases hepatic glucose output and promotes lipolysis and thermogenesis through beta-adrenergic-like cAMP signalling in adipose tissue. In isolation, glucagon receptor agonism tends to elevate plasma glucose markers in metabolic-readout in vitro assays -- which is why pairing it alongside GLP-1 and GIP agonism (both of which lower glucose markers) is the receptor-pharmacology rationale for the triple-agonist scaffold.
Diet-induced obesity (DIO) mice are the standard model for GLP-1 receptor agonist research and work well for retatrutide receptor-pharmacology studies. Db/db and ob/ob mice are used for diabetic-phenotype models. Non-human primate models are more physiologically relevant for incretin receptor pharmacology but obviously require appropriate institutional approvals. In vitro models include GLP-1R, GIPR, and GcgR stably transfected cell lines for receptor-specific binding and cAMP assays, or primary pancreatic islets for insulin/glucagon secretion measurements.
Retatrutide Research Starter Kit is supplied for laboratory research use only. Not for human or veterinary use. For research purposes only.
Researcher Confidence
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
SAME FIELDTirzepatide 10mg + Bacteriostatic Water 5ml + 2 x 3ml syringes + 5 x 1ml insulin syringes. Everything you need to begin research. For research purposes only. Bundle price: save EUR 25.97 vs buying the peptide, bacteriostatic water and syringe packs separately (about EUR 79.96 on their own).
SAME FIELDResearch-grade Liraglutide. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
10mgSAME FIELDResearch-grade Retatrutide + Cagrilintide Blend. ≥ 98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
SAME FIELDRetatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest in metabolic studies. Triple hormone receptor agonism (GIP/GLP-1/Glucagon) Metabolic pathway modulation research Energy homeostasis and body composition studies For research purposes only.